MIS-A patient PBMC responses to SARS-CoV-2 were largely similar to those of PBMCs from ICU patients with severe COVID-19, however IFNγ, TNFα; and IL-1β responses tended to be higher in MIS-A PBMCs although not significantly across all cases. This evidence concerns the gene IL1B and COVID-19.